Vuong Trieu Oncotelic Therapeutics, Inc. (OTLC) insider trading activity

Vuong Trieu is CHAIRMAN AND CEO of Oncotelic Therapeutics, Inc.. Currently has a direct ownership of 92.5 Million shares of OTLC, which is worth approximately $2.78 Million. The most recent transaction as insider was on Aug 23, 2024, when has been sold 500,000 shares (Common Stock) at a price of $0.02 per share, resulting in proceeds of $10,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 92.5M

0.54% 3M change

0.54% 12M change

Total Value Held $2.78 Million

Vuong Trieu Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 23 2024	BUY Open market or private purchase	$10,000 $0.02 p/Share	500,000 Added 0.54%	92,544,217 Common Stock
Jun 29 2023	BUY Open market or private purchase	$8,500 $0.02 p/Share	425,000 Added 0.46%	92,044,217 Common Stock
Jun 28 2023	BUY Open market or private purchase	$2,250 $0.03 p/Share	75,000 Added 0.08%	91,619,217 Common Stock
Jun 16 2023	BUY Open market or private purchase	$3,000 $0.03 p/Share	100,000 Added 0.11%	91,544,217 Common Stock
Jun 14 2023	BUY Open market or private purchase	$12,000 $0.03 p/Share	400,000 Added 0.44%	91,444,217 Common Stock
May 26 2023	BUY Open market or private purchase	$3,806 $0.03 p/Share	126,888 Added 0.14%	91,044,217 Common Stock
May 02 2023	BUY Open market or private purchase	$4,000 $0.04 p/Share	100,000 Added 0.11%	90,917,329 Common Stock
Dec 06 2022	BUY Open market or private purchase	$6,000 $0.05 p/Share	120,000 Added 0.13%	90,558,021 Common Stock
Nov 22 2022	BUY Open market or private purchase	$5,600 $0.08 p/Share	70,000 Added 0.08%	90,438,021 Common Stock
Sep 26 2022	BUY Open market or private purchase	$1,400 $0.07 p/Share	20,000 Added 0.02%	90,368,021 Common Stock
Aug 25 2022	BUY Open market or private purchase	$6,400 $0.08 p/Share	80,000 Added 0.09%	90,348,021 Common Stock
Jul 08 2021	BUY Grant, award, or other acquisition	-	259,302 Added 0.29%	90,527,323 Common Stock
Mar 31 2021	BUY Conversion of derivative security	-	74,455,719 Added 45.2%	90,268,021 Common Stock
Nov 19 2020	BUY Open market or private purchase	$9,595 $0.19 p/Share	50,500 Added 0.32%	15,812,308 Common Stock

Vuong Trieu

CHAIRMAN AND CEO

Agoura Hills, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OTLC shares.

Notify only if

Value

Insider Trading

Get notified when an Oncotelic Therapeutics, Inc. insider buys or sells OTLC shares.

Notify only if

Operation

Value

Type

News

Receive news related to Oncotelic Therapeutics, Inc.

Track Activities on OTLC

Account